Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
I note low point on graph. Can't seem to find Nominal value on IG but am on phone in the rain. Lowest point in 2015 is about 16p. Nominal value on Lse desktop site is 0.1p so it can go anywhere from here. Is it dipping down to touch a line on a graph? It's very early to fall so much and will now hv trouble getting back above the descending line. Also in no hurry at all today so I presume it is not finished. Clair1, any thoughts?
... thanks for your response. Let me digest what you have written and get back if I may. As you say, keep digging! Presumably the one thing finance companies do NOT want is collecting percentages of ailing AIM companies where ever they intend doing business instead of some good solid cash. (p.s. If you ever see the word DARWIN included in an RNS, then please run for the hills.)
REAC have a biomass plant at Newry which cost them £5.75M Due to underperformance of the original gasification technology, a decision was made to repower the project with a new technology and with a new technology provider. The gasification equipment purchased from EBIOSS will cost €4.963 million, fully payable in cash. REAC borrow 750,000K for exclusively project development REAC & EBIOSS change terms of loan and have now used £225K of the 750K on working capital. Plant still in mothballs. No sign of getting Newry plant functional (company think it will take 15 months from getting finance in place b4 generating electricity back into the grid). So now, with project development money spent on working capital, the company will have to borrow additional capital to do what they originally borrowed the money for. Which in itself was a fraction of the money needed to pay for the new plant (which they need to generate cash). In mean time company announce that it has planning permission for another, bigger biogas project at Clay Cross (The Company is currently in discussions to secure finance for the construction of the Facility and estimates that it will take approximately 18 months from obtaining finance to the final commissioning of the plant). Financial Summary · Group revenue of €0.13 million (H1 2014: €0.15 million) · Administrative costs of €0.25 million (H1 2014: €0.61 million) · Loss for the period from continuing operations of €0.4 million (H1 2014: Loss for period €1.3 million) ______________________________________________ Serious question. If my quick read of the RNS's is correct, there seems a lot of risk. What am I not seeing?
So it is the Labskin that they want to sell. I wonder if this is Brexit related? i.e. it was Labskin that was getting round the EU cosmetics testing regulations. I always thought it was a good idea and what first interested me in Venn. Seems like they were pumping money into it without seeing any prospects of a viable business. The article suggests that it was Labskin that was widening operating losses. Is there any figures around to suggest what sort of money Innovenn has been consuming and therefore what sort of financial picture one could expect post-selling? Thanks in advance.
I need to make a correction to my earlier post. I said "sitting nicely" on that major horizontal support. It should have read "bouncing strongly to the upside" off that major horizontal support! ha ha .......... Jim Lad.
Looking at this as the chart is looking good. Your posting intensity suggests you are familiar with the company. I have pasted an excerpt from the accounts posted on 1st April. Can you explain the following as i am having trouble understanding the complexity of their accounts: "The Group recorded a loss after taxation of £6,508,115 in the year ended 31 December 2015; however this included an exceptional non-cash finance charge of £8,066,000 based upon a revaluation of the embedded derivative associated with the Loan Notes issued by the Company in September 2013. The market value of the Company's Loan Notes is based upon the share price performance of the Company and only crystallises at the maturity date of 30 September 2018 or earlier on a change of control or scheme of arrangement." Thanks in advance